• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number 9-PDA2AS-05-04-L
Device Problems Improper or Incorrect Procedure or Method (2017); Obstruction of Flow (2423)
Patient Problem Obstruction/Occlusion (2422)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, aortic obstruction and left pulmonary artery obstruction was noted during follow up after implantation with a 5-6 amplatzer piccolo.The results of the investigation are inconclusive since the device was not returned for analysis.A review of the measurements as reported from the field was performed.Per the sizing table in the instructions for use, arten600042307 version a, the correct size piccolo occluder for the measurements provided was 04-02, smaller than the implanted device.The cause of the reported event could not be conclusively determined, however the implantation of a larger than recommended device could have contributed.
 
Event Description
Reference manufacturing report number: 2135147-2020-00091, 2135147-2020-00092, 2135147-2020-00093, 2135147-2020-00094.It was reported through a research article identifying amplatzer piccolo that may be related to a severe left pulmonary artery obstruction.Details are listed in the article, titled "device deformation and left pulmonary artery obstruction after transcatheter patent ductus arteriosus closure in preterm infants." it was reported in the article that in (b)(6) 2016, 14 patients underwent transcatheter patent ductus arteriosus (pda) closure.An 20 days old patient that weight 1672 grams with pda diameter of 2.95mm and pda length of 8.02mm was implanted with a 5-6 amplatzer piccolo.During follow up, aortic obstruction and severe left pulmonary artery obstruction was observed.The patient was asymptomatic and no intervention was performed.
 
Manufacturer Narrative
Correction information for b5, d1, d4, g4, g7, and h10.As reported in a research article, aortic obstruction and left pulmonary artery obstruction was noted during follow up after device implantation.The results of the investigation are inconclusive since the device was not returned for analysis.The cause of the reported event could not be conclusively determined.Please note, per the instructions for use, 600419-004 version a, " the amplatzer duct occluder ii additional sizes is contraindicated for patients who weigh less than 6 kg and are younger than 6 months in age".
 
Event Description
It was reported through a research article identifying amplatzer ado ii may be related to a severe left pulmonary artery obstruction.Details are listed in the article, titled "device deformation and left pulmonary artery obstruction after transcatheter patent ductus arteriosus closure in preterm infants".It was reported in the article that in (b)(6) 2016, 14 patients underwent transcatheter patent ductus arteriosus (pda) closure.An 20 days old patient that weight 1672 grams with pda diameter of 2.95mm and pda length of 8.02mm was implanted with a 5-6 amplatzer ado ii.During follow up, aortic obstruction and severe left pulmonary artery obstruction was observed.The patient was asymptomatic and no intervention was performed.
 
Manufacturer Narrative
Correction information for d2 additional information for g4, g7, h2, h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER DUCT OCCLUDER II ADDITIONAL SIZES
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key9783125
MDR Text Key183946277
Report Number2135147-2020-00090
Device Sequence Number1
Product Code MAE
Combination Product (y/n)N
PMA/PMN Number
P020024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup,Followup
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-PDA2AS-05-04-L
Device Catalogue Number9-PDAP-05-04-L
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age20 DA
Patient Weight2
-
-